Investigation of abdominal pain management in diarrhea-predominant irritable bowel syndrome via short-chain fatty acids/GLP-1 axis

Medicine & Life Sciences

1. Volatile Fatty Acids 100%
2. Irritable Bowel Syndrome 90%
3. Abdominal Pain 70%
4. Glucagon-Like Peptide 1 67%
5. Gastrointestinal Microbiome 31%
6. Hypersensitivity 21%
7. Microbiota 15%
8. Fecal Microbiota Transplantation 15%
9. Enteroendocrine Cells 15%
10. Diarrhea 13%
11. valyl(10)-glucagon-like peptide (7-37) 11%
12. Serum 7%
13. Propionates 6%
14. Butyrates 6%
15. Pain Management 5%
16. Acetates 5%